Haleon (HLN) Preferred Shares (2022 - 2023)
Haleon (HLN) posted Preferred Shares of -$31.3 million for Q2 2023, down 6.69% on a QoQ basis from -$29.3 million in Q4 2022.
Haleon (HLN) Preferred Shares (2022 - 2023) Analysis & Trends
Haleon's Preferred Shares history runs 2 years deep, the most recent figure standing at -$31.3 million for Q2 2023.
- Quarterly Preferred Shares changed N/A year-over-year to -$31.3 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$31.3 million (changed N/A YoY) and the FY2022 annual result came in at -$30.9 million, changed N/A from the prior year.
- Preferred Shares was -$31.3 million for Q2 2023 at Haleon, down from -$29.3 million in the prior quarter.
- Across five years, Preferred Shares topped out at -$29.3 million in Q4 2022 and bottomed at -$31.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -31.28 Mn |
| Dec 31, 2022 | -29.32 Mn |